Camber Pharmaceuticals Achieves Full DSCSA Compliance Ahead of 2024 Deadline
核心洞察
Camber Pharmaceuticals has successfully implemented comprehensive DSCSA compliance measures, achieving 100% aggregation from bottle to pallet level for pharmaceutical product tracking.
The company has demonstrated exceptional performance in customer testing with 95-100% success rates, utilizing TraceLink (搜索)'s Verification Routing Services for product authentication since 2022.
In preparation for the November 2024 DSCSA deadline, Camber is increasing inventory levels to support customers whose other suppliers may not achieve full compliance.
Camber Pharmaceuticals has announced complete readiness for the Drug Supply Chain Security Act (DSCSA) requirements, positioning itself at the forefront of pharmaceutical supply chain security and traceability compliance well ahead of the November 2024 deadline.
Advanced Traceability Implementation
The company has achieved a significant milestone with 100% aggregation capabilities from bottle to pallet level, establishing a comprehensive track-and-trace system across their entire product line. This implementation ensures complete visibility and security throughout the pharmaceutical supply chain.
Extensive testing with multiple customers has yielded impressive results, with success rates ranging between 95-100%. Since November 2022, Camber has been utilizing TraceLink (搜索)'s Verification Routing Services (VRS) platform for robust product authentication, demonstrating their commitment to supply chain integrity.
Technical Infrastructure and Data Management
Camber's compliance framework encompasses several critical components:
- Advanced EPCIS (Electronic Product Code Information Services) data testing with all customers
- Comprehensive Master Data Management systems
- Sophisticated Inventory Control mechanisms
- Integration of Global Trade Item Numbers (GTINs) through Healthcare Distribution Alliance channels
Strategic Preparedness and Customer Support
In a proactive move to ensure uninterrupted supply chain operations, Camber is strategically increasing its inventory levels. This initiative aims to support customers who may face challenges with other suppliers not yet achieving full DSCSA compliance.
"Our early adoption and comprehensive implementation of DSCSA requirements reflect our commitment to supply chain security and customer service," stated a Camber representative. "We're not just meeting the standards – we're exceeding them to ensure our partners can rely on us during this critical transition period."
Supply Chain Security Measures
The company's robust verification and exception handling processes ensure:
- Real-time product authentication
- Seamless integration with customer systems
- Efficient handling of supply chain exceptions
- Enhanced end-to-end visibility
These implementations position Camber as a reliable partner in pharmaceutical distribution, ensuring compliance with federal regulations while maintaining the highest standards of product safety and security.